CLINICAL_TRIALS ClinicalTrials.gov record update

A Trial to Assess the Safety and Efficacy of Epcoritamab-containing Combination Salvage Therapy Followed by Autologous Stem Cell Transplantation and Epcoritamab Consolidation in Patients With Relapsed Large B-cell Lymphoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06287398
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:22.090401+00:00
Published At: 2024-07-22T00:00:00+00:00
Record Updated At: 2024-07-22
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["DLBCL - Diffuse Large B Cell Lymphoma", "High-grade B-cell Lymphoma", "High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements", "DLBCL, Nos Genetic Subtypes", "High Grade B-Cell Lymphoma, Not Otherwise Specified", "Follicular Large Cell Lymphoma, Relapsed", "Follicular Large Cell Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-07-22"
protocolSection.identificationModule.nctId: "NCT06287398"
protocolSection.identificationModule.officialTitle: "A Trial to Assess the Safety and Efficacy of Epcoritamab-containing Combination Salvage Therapy Followed by Autologous Stem Cell Transplantation and Epcoritamab Consolidation in Patients With Relapsed Large B-cell Lymphoma"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.